TNFSF10 and cancer: Cisplatin sensitized mouse glioblastoma tumors to stem cell-delivered TRAIL in vitro and in vivo [139], suggesting that combinatorial therapies effectively sensitize cancer cells to stem cell-delivered TRAIL.